Literature DB >> 1610832

Role of phosphorylated aminoacyl residues in generating atypical consensus sequences which are recognized by casein kinase-2 but not by casein kinase-1.

J W Perich1, F Meggio, E C Reynolds, O Marin, L A Pinna.   

Abstract

Casein kinase-2 (CK-2) is a ubiquitous Ser/Thr specific protein kinase that recognizes phosphorylatable residues located upstream of acidic determinants, its consensus sequence being Ser(Thr)-Xaa-Xaa-Acidic. Here we show that the phosphotetrapeptide AcSer(P)-Ser(P)-Ser-Ser(P), which is devoid of the canonical consensus sequence, is nevertheless phosphorylated by CK-2 with rates comparable to that of typical peptide substrates Ser-Glu-Glu-Glu-Glu-Glu and Arg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu routinely employed for assaying CK-2 activity. The phosphopeptide AcSer(P)-Ser-Ser(P) [but not Ac-Ser-Ser(P)-Ser(P) or AcSer(P)-Ser(P)-Ser] is also phosphorylated albeit less efficiently than AcSer(P)-Ser(P)-Ser-Ser(P). Further N-terminal elongation with additional phosphoseryl residues to give the peptides AcSer(P)-Ser(P)-Ser(P)-Ser-Ser(P) and AcSer(P)-Ser(P)-Ser(P)-Ser(P)-Ser-Ser(P) does not improve but rather slightly decreases the phosphorylation efficiency by CK-2. These two peptides are conversely excellent substrates for CK-1, which does not appreciably phosphorylate either AcSer(P)-Ser-Ser(P) or AcSer-(P)-Ser(P)-Ser-Ser(P). Either individual or multiple replacement of the phosphorylated residues with glutamic acid in the peptide AcSer(P)-Ser(P)-Ser-Ser(P) drastically reduces the phosphorylation efficiency by CK-2, the phosphoseryl residue at position -2 playing an especially crucial role which cannot be surrogated by glutamyl residues.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610832     DOI: 10.1021/bi00140a027

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  CK2, a protein kinase of the next millennium.

Authors:  G Dobrowolska; F J Lozeman; D Li; E G Krebs
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Isoform specific phosphorylation of p53 by protein kinase CK1.

Authors:  Andrea Venerando; Oriano Marin; Giorgio Cozza; Victor H Bustos; Stefania Sarno; Lorenzo Alberto Pinna
Journal:  Cell Mol Life Sci       Date:  2009-12-30       Impact factor: 9.261

3.  Aurora-A site specificity: a study with synthetic peptide substrates.

Authors:  Stefano Ferrari; Oriano Marin; Mario A Pagano; Flavio Meggio; Daniel Hess; Mahmoud El-Shemerly; Agnieszka Krystyniak; Lorenzo A Pinna
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

4.  A multifunctional network of basic residues confers unique properties to protein kinase CK2.

Authors:  S Sarno; P Vaglio; L Cesaro; O Marin; L A Pinna
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

Review 5.  Casein kinase II in signal transduction and cell cycle regulation.

Authors:  D W Litchfield; B Lüscher
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

6.  Generation of protein kinase Ck1alpha mutants which discriminate between canonical and non-canonical substrates.

Authors:  Victor H Bustos; Oriano Marin; Flavio Meggio; Luca Cesaro; Catherine C Allende; Jorge E Allende; Lorenzo A Pinna
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

7.  The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131.

Authors:  Jordi Vilardell; Cristina Girardi; Oriano Marin; Giorgio Cozza; Lorenzo A Pinna; Maria Ruzzene
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

8.  Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis.

Authors:  Mario A Pagano; Giorgio Arrigoni; Oriano Marin; Stefania Sarno; Flavio Meggio; Kate J Treharne; Anil Mehta; Lorenzo A Pinna
Journal:  Biochemistry       Date:  2008-07-03       Impact factor: 3.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.